Navigation Links
HeartSine® Increases AED System Warranty to Longest in the Industry
Date:5/31/2011

NEWTOWN, Pa., May 31, 2011 /PRNewswire/ -- HeartSine Technologies, Inc, a world leader in personal and public access defibrillators, has increased its system warranty period to an exclusive 10 years on its popular HeartSine® samaritan® PAD 300P Public Access Defibrillator (PAD) for the treatment of Sudden Cardiac Arrest. The samaritan PAD currently is the fastest growing AED. The life of its Pad-Pak® device, a battery and electrode contained in an integrated cartridge has also been increased to four years. Both the life of the Pad-Pak and the samaritan PAD's product warranty are the longest available in the Automated External Defibrillator (AED) industry.

HeartSine's commitment to innovation and significant investments in research and development have resulted in industry advanced technology, firmware, software and components which meet and exceed AED clinical efficacy standards. This Innovation enables HeartSine to provide end users with exceptional product reliability and the lowest cost of ownership.

"At HeartSine, our passion is to continue to design and develop compact, easy-to-use and extremely reliable AED devices to customers where our superior lifesaving technology helps save the lives of colleagues, customers and friends," said Marc Lawrence, HeartSine senior vice president. "Our 10-year warranty and 4-year Pad-Pak life has helped make the best life saving device even better."

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of proprietary technologies and quality products. The HeartSine® samaritan® PAD Public Access Defibrillator is a medical device especially designed for public access use, to administer lifesaving treatment for Sudden Cardiac Arrest. It is a sophisticated, lightweight Automated External Defibrillator designed for rescuers of all skill levels and is ideal for sports facilities, schools, churches and all businesses.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Contact: Marc Lawrence
Phone: 215.860.8100
marc.lawrence@heartsine.com


'/>"/>
SOURCE HeartSine Technologies, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
3. Demand for VScan Dengue Fever Test Kits Increases
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
8. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
9. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
10. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
11. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Urinary Incontinence Drugs Price ... in the global Urinary Incontinence market. The research answers the ... drugs marketed for Urinary Incontinence and their clinical attributes? How are ...
(Date:2/23/2017)... Research and Markets has announced the addition ... - 2016" report to their offering. ... The latest research Autism Spectrum Disorder ... and benchmarks in the global Autism Spectrum Disorder market. The ... are the key drugs marketed for Autism Spectrum Disorder and their ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... , ... With ProGlass Prism users now have the ability to simulate prism ... position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor ... Prism users are given the tools and effects to generate a fractal prismatic ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
Breaking Medicine News(10 mins):